Mease, P. J., Kavanaugh, A., Reimold, A., Tahir, H., Rech, J., Hall, S., . . . Pricop, L. Secukinumab in the treatment of psoriatic arthritis: Efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMease, Philip J., et al. Secukinumab in the Treatment of Psoriatic Arthritis: Efficacy and Safety Results Through 3 Years from the Year 1 Extension of the Randomised Phase III FUTURE 1 Trial. BMJ Publishing Group.
MLA (9th ed.) CitationMease, Philip J., et al. Secukinumab in the Treatment of Psoriatic Arthritis: Efficacy and Safety Results Through 3 Years from the Year 1 Extension of the Randomised Phase III FUTURE 1 Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.